Wall Street Analysts Predict a 32.69% Upside in Chemed (CHE): Here's What You Should Know

Core Viewpoint - Chemed (CHE) has shown a recent price increase and analysts suggest significant upside potential based on price targets, with a mean target indicating a 32.7% increase from the current price [1][2]. Price Targets and Analyst Estimates - The mean price target for CHE is $578.5, with a standard deviation of $19.97, indicating a consensus among analysts [2]. - The lowest price target is $550.00, suggesting a 26.2% increase, while the highest target is $595.00, indicating a potential 36.5% increase [2]. - A low standard deviation among price targets suggests strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown optimism regarding CHE's earnings prospects, with a positive trend in earnings estimate revisions [4][11]. - Over the last 30 days, two earnings estimates have been revised upward, leading to a 1.9% increase in the Zacks Consensus Estimate [12]. - CHE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Investment Considerations - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to potential biases in analyst estimates [3][10]. - The correlation between earnings estimate revisions and stock price movements suggests that the direction indicated by price targets may be a useful guide for further research [11][14].